Echocardiographic findings in HIV disease and AIDS

Echocardiography

Volumn 22, Issue 10, 2005, Pages 861-866

  Velasquez, Enrique M ^a   Glancy, David Luke ^a   Helmcke, Fredrick ^a   Kerut, Edmund Kenneth ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEART CLINIC OF LOUISIANA   (United States)

Author keywords

AIDS; Echocardiography; HIV

Indexed keywords

AMPHOTERICIN B; DOXORUBICIN; FOSCARNET; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CARDIOTOXICITY; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ENDOCARDITIS; HEART LEFT VENTRICLE FAILURE; HEART TUMOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MYCOSIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; ADULT; CHEMICALLY INDUCED DISORDER; CHILD; HEART DISEASE; HEART MUSCLE ISCHEMIA; METHODOLOGY; MIDDLE AGED; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; ECHOCARDIOGRAPHY; HEART DISEASES; HIV INFECTIONS; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 33646249400     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2005.00136.x     Document Type: Article

References (27)

1. AIDS epidemic update: December 2003. Available at: http://www.who.int/ hiv/pub/epidemiology/epi2003/en/
2. Blanchard D, Hagenhoff C, Chow L, et al: Reversibility of cardiac abnormalities in human immunodeficiency virus infected individuals: A serial echocardiographic study. JACC 1991;17:1270-1276.
3. Heidenreich P, Eisenberg M, Kee L, et al: Pericardial effusion in AIDS. Circulation 1995;92:3229-3234.
4. Rerkpattanapipat P, Wongpraparut N, Jacobs L, et al: Cardiac manifestations of AIDS. Arch Intern Med 2000;160:602-608.
5. D'amati G, Di Gioia C, Gallo P: Pathological findings of HIV-associated cardiovascular disease. Ann N Y Acad Sci 2001;946:23-45.
6. Flum D, McGinn J, Tyras D: The role of the pericardial window in AIDS. Chest 1995;107:1522-1525.
7. D'Cruz I, Calderon E, Kalife K, et al: Left ventricular diastolic compression in acquired immunodeficiency syndrome with large, nonloculated pericardial effusion. Am Heart J 1997;133:383-384.
8. Herskowitz A, Vlahov D, Willoughby SB, et al: Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993;71:955-958.
9. Barbaro G, Barbarini G, Di Lorenzo G: Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: A multicenter echocardiographic and echo-Doppler study. AIDS Res Hum Retroviruses 1996;12:1559-1563.
10. Barbaro G, Di Lorenzo G, Grisorio B, et al: Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-1099.
11. Anderson D, Virmani R, Reilly J, et al: Prevalent myocarditis in the adquired immunodeficiency syndrome. JACC 1988;11:792-799.
12. Fischer S, Lipshultz S: Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann N Y Acad Sci 2001;946:13-22.
13. Longo-Mbenza B, Seghers L, Kintochi E, et al: Assesment of ventricular diastolic function in AIDS patients from Congo: A Doppler echocardiographic study. Heart 1998;80:184-189.
14. Hernandez F, Gascuena R, Escribano P, et al: Diastolic dysfunction in human immunodeficiency virus infection. Rev Esp Cardiol 2001;54:1183-1189.
15. Nahass R, Weinstein M, Bartels J, et al: Infective endocarditis in intravenous drug users: A comparison of human immunodeficiency virus type 1-negative and positive patients. J Infect Dis 1990;162:967-970.
16. Cicalini S, Forcina G, De Rosa F: Infective endocarditis in patients with human immunodeficiency virus infection. J Infect 2001;42:267-271.
17. Kelley G, Stellingworth M, Mittal S, et al: Dyspnea in a woman infected with HIV. J La State Med Soc 2001;153:529-533.
18. Patel M, Thomson L, Meine T, et al: An intracardiac mass in a young man with congenitally acquired HIV. Cardiol Rev 2004;12:126-130.
19. Paraf F, Berrebi A, Chauvaud S, et al: Mitral papillary fibroelastoma in a HIV infected patient. Presse Med 1999;28:962-964.
20. Petrosillo N, Pellicelli A, Boumis E, et al: Clinical manifestation of HIV-related pulmonary hypertension. Ann N Y Acad Sci 2001;946:223-235.
21. Mehta N, Khan I, Mehta R, et al: HIV-related pulmonary hypertension. Chest 2000;118:1133-1141.
22. Zuber J, Calmy A, Evison J, et al: Pulmonary arterial hypertension related to HIV infection: Improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004;38:1178-1185.
23. Friis-Møller N, Weber R, d'Arminio M, et al: Cardiovascular risk factors in HIV patients-association with antiretroviral therapy: Results from the DAD Study. AIDS 2003;17:1179-1193.
24. Herskowitz A, Willoughby S, Baughman K, et al: Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: A report of six cases. Ann Intern Med 1992;116:311-313.
25. Meng Q, Lima J, Lai H, et al: Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. JAIDS 2002;30:306-310.
26. Keesler M, Fischer S, Lipshultz S: Cardiac manifestations of HIV infection in infants and children. Ann N Y Acad Sci 2001;946:169-178.
27. 2 HIV study.J Pediatr 2002;141:327-334.